Search

By Industry Solutions (2)
By Phase (1)
By Molecule Type (1)
By Therapeutic Area (3)
Covance Events (9)
Geography (3)
Keywords (10)

Filters

Showing results 49 - 64 of 91813 for .

Showing results 49 - 64 of 91813 for .

Covance Teamwork and Xcellerate® Delivers Oncology Study 1 Year Early
Covance's superior resource forecasting, data management, and teamwork facilities delivery of pivotal study with new Oncology compound more than 1 year ahead of schedule
Why Comparability Studies are the Key to a Biosimilar's Success
It is an exciting time for biosimilars. Learn why you need to look at biosimilars development from an integrated standpoint.
Delivering Globally Consistent Data from In-House ANA-IFA Assays
Learn how the ANA-IFA test is the "gold standard" for ANA testing -How meeting regulatory standards is not enough to be competitive in today's (IMID) market
Impacting Clinical Outcomes: Computational Analysis of Complex Genomics Data Sets
Computational Biology group ensures high-quality genomics data through industry leading lab informatics, experiment design, statistical analysis, etc.
Brand Protection in Food and Dietary Supplement Industries Requires Expertise and Experience [Infographic]
Covance offers nutritional chemistry and food safety testing and consulting. And 15 of the 20 largest global food companies choose to work with Covance.
Shaping Global Standards for Bioanalysis
The Global Bioanalysis Consortium (GBC) is an industry-driven global effort to propose best practices based on scientific principles for bioanalytical work.
"Fail Fast" Using Toxicology Endpoints in Pharmacology Studies
Success in drug development is dependent on robust "fail fast" strategy that includes safety / toxicology endpoints into lead optimization pharmacology studies.
Contract Lifecycle Management: "The New Normal"
Life science companies are operating in a highly-competitive, complex and regulated market.
A CRO Partner in Rx/CDx Co-Development
Leading the field among CROs in adding complementary capabilities and strategic advice where pharma sponsors need help developing new companion diagnostics (CDx).
Complement your Clinical Research Goals [Infographic]
Our expertise in biologics and small molecules can fully integrate preclinical safety data into a robust protocol, to help you achieve drug development milestones faster.
Maximize Phase I Study Timelines through Innovative Clinical Trial Design
New protocols for clinical trial design among drug developers bring first subject visit for proof-of-concept study forward by months and increase savings.
Addressing the Challenges of Abuse Liability Testing - Meeting Regulatory Requirements and Study Design
Called abuse liability testing, this stage of drug development was first officially recognized in 1970 with the U.S. Controlled Substances Act.
Using Next-Generation Sequencing to Detect Epigenetic Alterations - The Impact on Clinical Oncology
...the epigenetic landscape has already generated recent breakthroughs in the detection, treatment and prognosis of many diseases, including cancer.
Obtaining Early Insights Into Safety and Efficacy: The Benefits of Preclinical In Vivo Imaging
...in vivo imaging benefits... For the past 25 years, studies have relied on in vivo imaging as a method to quantify treatment response...
A Biotech's Path to Achieving your Molecule's Full Potential at Proof of Concept (PoC)
Proof of concept (PoC) is a critical milestone when considering when to partner with or purchase a compound from a small biotech.
Accelerating Candidate Selection: Solutions for Lead Optimization Pharmacology & Toxicology
Lead Optimization Pharmacology & Toxicology designed to help you select the best molecule for candidate selection and further development.